Barry E. Greene
2009 - Alnylam Pharmaceuticals
In 2009, Barry E. Greene earned a total compensation of $1M as President and Chief Operating Officer at Alnylam Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $38,610 |
|---|---|
| Option Awards | $572,299 |
| Salary | $390,000 |
| Other | $5,992 |
| Total | $1,006,901 |
Greene received $572.3K in option awards, accounting for 57% of the total pay in 2009.
Greene also received $38.6K in non-equity incentive plan, $390K in salary and $6K in other compensation.
Rankings
In 2009, Barry E. Greene's compensation ranked 4,445th out of 9,885 executives tracked by ExecPay. In other words, Greene earned more than 55.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,445 out of 9,885 | 55th |
Division Manufacturing | 1,582 out of 3,690 | 57th |
Major group Chemicals And Allied Products | 309 out of 871 | 65th |
Industry group Drugs | 187 out of 643 | 71st |
Industry Pharmaceutical Preparations | 147 out of 446 | 67th |
Source: SEC filing on May 2, 2011.
Greene's colleagues
We found four more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2009.
2009
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2009
Akshay Vaishnaw
Alnylam Pharmaceuticals
Senior Vice President, Clinical Research
2009
John Schmidt
Alnylam Pharmaceuticals
Chief Scientific Officer
2009
Patricia Allen
Alnylam Pharmaceuticals